×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABBV – abbvie inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABBV
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/23
04:30 pm
abbv
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus [Yahoo! Finance]
Low
Report
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus [Yahoo! Finance]
4/23
04:24 pm
abbv
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S. [TheStreet.com]
Low
Report
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S. [TheStreet.com]
4/23
04:11 pm
abbv
Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4 [Yahoo! Finance]
Low
Report
Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4 [Yahoo! Finance]
4/23
04:05 pm
abbv
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
Low
Report
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
4/23
09:00 am
abbv
AbbVie (ABBV) was given a new $294.00 price target by Piper Sandler.
Low
Report
AbbVie (ABBV) was given a new $294.00 price target by Piper Sandler.
4/22
09:36 pm
abbv
Does AbbVie's Durham AI Plant and Ovarian Cancer Data Reframe the Bull Case for ABBV? [Yahoo! Finance]
Low
Report
Does AbbVie's Durham AI Plant and Ovarian Cancer Data Reframe the Bull Case for ABBV? [Yahoo! Finance]
4/22
07:12 pm
abbv
AbbVie to build $1.4B pharmaceutical manufacturing campus in NC, create hundreds of jobs in Durham [Yahoo! Finance]
Low
Report
AbbVie to build $1.4B pharmaceutical manufacturing campus in NC, create hundreds of jobs in Durham [Yahoo! Finance]
4/22
06:03 pm
abbv
AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development [Yahoo! Finance]
Low
Report
AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/3
04:06 pm
abbv
Form 8-K AbbVie Inc. For: Apr 03
Low
Report
Form 8-K AbbVie Inc. For: Apr 03
4/2
05:01 pm
abbv
Form 4 AbbVie Inc. For: Mar 31 Filed by: RAPP EDWARD J
Low
Report
Form 4 AbbVie Inc. For: Mar 31 Filed by: RAPP EDWARD J
4/2
05:01 pm
abbv
Form 4 AbbVie Inc. For: Mar 31 Filed by: Quaggin Susan E
Low
Report
Form 4 AbbVie Inc. For: Mar 31 Filed by: Quaggin Susan E
4/2
05:01 pm
abbv
Form 4 AbbVie Inc. For: Mar 31 Filed by: Alpern Robert J
Low
Report
Form 4 AbbVie Inc. For: Mar 31 Filed by: Alpern Robert J
3/26
03:06 pm
abbv
Form SCHEDULE 13G/A AbbVie Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A AbbVie Inc. Filed by: VANGUARD GROUP INC
3/23
05:10 pm
abbv
Form ARS AbbVie Inc. For: Dec 31
Low
Report
Form ARS AbbVie Inc. For: Dec 31
3/23
04:59 pm
abbv
Form DEF 14A AbbVie Inc. For: May 08
Low
Report
Form DEF 14A AbbVie Inc. For: May 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/26
Form PX14A6G AbbVie Inc. Filed by: United Church Funds, Inc.
9.7%
3/3 Form 4 AbbVie Inc. For: Feb 28 Filed by: Schumacher Laura J 4.8%
3/19 Israel OKs use of generic AbbVie drug to treat coronavirus despite patent [Reuters (UK)] 4.7%
2/7 Q4/2019 12/31/2019 EPS 2.210 ZacksConsensus 2.200 ActVsEst 0.010 - Beat 4.6%
3/23 Abbvie: Buy The Coronavirus Dip For These 3 Reasons [Seeking Alpha] 4.5%
6/27 AbbVie: $63 Billion Allergan Acquisition Just What The Doctor Ordered [Seeking Alpha] 3.7%
6/25 AbbVie Inc. (ABBV) CEO Rick Gonzalez on Acquisition of Allergan Conference Call (Transcript) [Seeking Alpha] 3.6%
11/8 AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia 3.6%
8/16 Form 4 AbbVie Inc. For: Aug 14 Filed by: Gosebruch Henry O 3.3%
6/26 AbbVie Inc (NYSE: ABBV) had its "hold" rating re-affirmed by analysts at Citigroup Inc. 3.2%
3/3 Form 4 AbbVie Inc. For: Feb 28 Filed by: Schumacher Laura J 4.8%
3/19 Israel OKs use of generic AbbVie drug to treat coronavirus despite patent [Reuters (UK)] 4.7%
2/7 Q4/2019 12/31/2019 EPS 2.210 ZacksConsensus 2.200 ActVsEst 0.010 - Beat 4.6%
3/23 Abbvie: Buy The Coronavirus Dip For These 3 Reasons [Seeking Alpha] 4.5%
6/27 AbbVie: $63 Billion Allergan Acquisition Just What The Doctor Ordered [Seeking Alpha] 3.7%
6/25 AbbVie Inc. (ABBV) CEO Rick Gonzalez on Acquisition of Allergan Conference Call (Transcript) [Seeking Alpha] 3.6%
11/8 AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia 3.6%
8/16 Form 4 AbbVie Inc. For: Aug 14 Filed by: Gosebruch Henry O 3.3%
6/26 AbbVie Inc (NYSE: ABBV) had its "hold" rating re-affirmed by analysts at Citigroup Inc. 3.2%
TOP News Decliners
6/25
AbbVie nears deal to buy Allergan for more than $60 bln - WSJ [Reuters]
-11.8%
3/20 Form 4 AbbVie Inc. For: Mar 18 Filed by: Durkin Brian L -6.5%
3/12 AbbVie Receives European Commission Approval of VENCLYXTO® Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia -4.1%
2/24 Form 4 AbbVie Inc. For: Feb 20 Filed by: Durkin Brian L -3.9%
10/1 Lanny's October Dividend Stock Watch List [Seeking Alpha] -3.6%
3/10 Generic anti-malarial may treat COVID-19 - Raymond James [Seeking Alpha] -3.0%
2/27 AbbVie Inc (NYSE: ABBV) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -2.9%
3/17 AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction -2.7%
4/7 Form PX14A6G AbbVie Inc. Filed by: ZEVIN ASSET MANAGEMENT LLC -2.6%
2/12 Results from Chinese drug trials for coronavirus due in weeks: expert [Reuters (UK)] -2.6%
3/20 Form 4 AbbVie Inc. For: Mar 18 Filed by: Durkin Brian L -6.5%
3/12 AbbVie Receives European Commission Approval of VENCLYXTO® Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia -4.1%
2/24 Form 4 AbbVie Inc. For: Feb 20 Filed by: Durkin Brian L -3.9%
10/1 Lanny's October Dividend Stock Watch List [Seeking Alpha] -3.6%
3/10 Generic anti-malarial may treat COVID-19 - Raymond James [Seeking Alpha] -3.0%
2/27 AbbVie Inc (NYSE: ABBV) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -2.9%
3/17 AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction -2.7%
4/7 Form PX14A6G AbbVie Inc. Filed by: ZEVIN ASSET MANAGEMENT LLC -2.6%
2/12 Results from Chinese drug trials for coronavirus due in weeks: expert [Reuters (UK)] -2.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: